Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The oncogenic roles and clinical implications of YAP/TAZ in breast cancer
Juan Luo, Hailin Zou, Yibo Guo, et al.
British Journal of Cancer (2023)
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)
Reyhaneh Farghadani, Rakesh Naidu
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115170-115170
Open Access | Times Cited: 45
Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer
Pathea Bruno, Aneeta Arshad, Maria-Raluca Gogu, et al.
Life (2025) Vol. 15, Iss. 1, pp. 126-126
Open Access | Times Cited: 2
Tyrosine phosphorylation-mediated YAP1-TFAP2A interactions coordinate transcription and trastuzumab resistance in HER2+ breast cancer
Hailin Zou, Juan Luo, Yibo Guo, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101051-101051
Open Access | Times Cited: 12
Correlation analysis of DLG5 and PD-L1 expression in triple-negative breast cancer
Jingmin Che, Qing Chen, Xusheng Wang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP
Zelin Tian, Chen Xu, Weixiang He, et al.
Cancer Letters (2023) Vol. 577, pp. 216439-216439
Closed Access | Times Cited: 14
Nuclear Import and Export of YAP and TAZ
Michael Kofler, András Kapùs
Cancers (2023) Vol. 15, Iss. 20, pp. 4956-4956
Open Access | Times Cited: 12
ID4-dependent secretion of VEGFA enhances the invasion capability of breast cancer cells and activates YAP/TAZ via integrin β3-VEGFR2 interaction
Anna Benedetti, Chiara Turco, Enzo Gallo, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 4
The importance of protein domain mutations in cancer therapy
Kiran Kumar Chitluri, Isaac Arnold Emerson
Heliyon (2024) Vol. 10, Iss. 6, pp. e27655-e27655
Open Access | Times Cited: 4
Innovative role of the antidepressant imipramine in esophageal squamous cell carcinoma treatment: Promoting apoptosis and protective autophagy
Shihao Bao, Yifan Zhang, Jingtong Zeng, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113969-113969
Closed Access
Breast cancer stem cell: Role in pathogenesis
Riya Sharma, Vikas Tiwari, Seema Seema, et al.
Elsevier eBooks (2025), pp. 207-224
Closed Access
Roles of Post-Translational Modifications of Transcription Factors Involved in Breast Cancer Hypoxia
Logan Seymour, Niyogushima Nuru, Kaya R. Johnson, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 645-645
Open Access
Precise targeting of transcriptional co-activators YAP/TAZ annihilates chemoresistant brCSCs by alteration of their mitochondrial homeostasis
Priyanka Dey Talukdar, K. Pramanik, Priya Gatti, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Molecular mechanisms of Hippo pathway in tumorigenesis: therapeutic implications
Mohamed J. Saadh, Hanan Hassan Ahmed, Radhwan Abdul Kareem, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Peptide-Modified Lipid Nanoparticles Boost the Antitumor Efficacy of RNA Therapeutics
Gangyin Zhao, Ye Zeng, Wanli Cheng, et al.
ACS Nano (2025)
Closed Access
Mammary stem cells: molecular cues, orchestrated regulatory mechanisms and its implications in breast cancer
Mengna Zhang, Lingxian Zhang, Jie Liu, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2025)
Closed Access
Targeting the Hippo Pathway in Breast Cancer: A Proteomic Analysis of Yes-Associated Protein Inhibition
Sevinç Yanar, Merve Gülşen Bal Albayrak, Tuğcan Korak, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 3943-3943
Open Access
Resveratrol induces ferroptosis in triple-negative breast cancer through NEDD4L-mediated GPX4 ubiquitination and degradation
Erhao Zhang, Yichao Wang, Hongli Zhang, et al.
Free Radical Biology and Medicine (2025) Vol. 235, pp. 231-247
Closed Access
Identification of YAP regulators through high-throughput screening and NanoBiT-based validation-drug repositioning for cancer therapy
Jae‐Sung Lim, Eui-Hwan Choi, Yujeong Kim, et al.
Animal Cells and Systems (2025) Vol. 29, Iss. 1, pp. 325-338
Open Access
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells
Chiara Bertagnin, Lorenzo Messa, Matteo Pavan, et al.
Cancer Letters (2023) Vol. 571, pp. 216331-216331
Open Access | Times Cited: 9
Matrix viscoelasticity controls epithelial cell mechanobiology through dimensionality
Giuseppe Ciccone, Mariana Azevedo González Oliva, Marie Versaevel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway
Bo Shu, Yingxia Zhou, Guoqiong Lei, et al.
Cancer Science (2024) Vol. 115, Iss. 5, pp. 1476-1491
Open Access | Times Cited: 3
Transcriptional regulation of CYR61 and CTGF by LM98: a synthetic YAP-TEAD inhibitor that targets in-vitro vasculogenic mimicry in glioblastoma cells
Marie‐Eve Roy, Carolane Veilleux, Alexis Paquin, et al.
Anti-Cancer Drugs (2024)
Open Access | Times Cited: 3
CDK9 inhibitors for the treatment of solid tumors
Christiana Mo, Wei Ning, T. Li, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116470-116470
Closed Access | Times Cited: 3
Regulation of the tumor immune microenvironment by the Hippo Pathway: Implications for cancer immunotherapy
Chang Liu, Yang Song, Deming Li, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110586-110586
Closed Access | Times Cited: 8
Multidimensional quantitative phenotypic and molecular analysis reveals neomorphic behaviors of p53 missense mutants
Anasuya Pal, Laura González‐Malerva, Seron Eaton, et al.
npj Breast Cancer (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top